Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Reidenberg

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1974
N-acetylprocainamide: an active metabolite of procainamideD E Drayer, M M Reidenberg, R W Sevy
Clinical Pharmacology and Therapeutics|July 1, 1976
Pentobarbital elimination in patients with poor renal functionM M Reidenberg, D T Lowenthal, W Briggs, et al.
Journal of Clinical Epidemiology|October 1, 1994
Breast silicone implants and risk of systemic lupus erythematosusB L Strom, M M Reidenberg, B Freundlich, et al.
Clinical Pharmacology and Therapeutics|January 1, 1982
Age and renal clearance of cimetidineD E Drayer, J Romankiewicz, B Lorenzo, et al.
Annals of Internal Medicine|July 1, 1981
Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndromeJ Kluger, D E Drayer, M M Reidenberg, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1993
Urinary clusterin in chronic nephrotoxicity in the ratS Eti, C Y Cheng, A Marshall, et al.
Clinical Pharmacology and Therapeutics|January 1, 1980
Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with ageD E Drayer, M Hughes, B Lorenzo, et al.
Clinical Pharmacology and Therapeutics|June 1, 1975
Polymorphic acetylation procainamide in manM M Reidenberg, D E Drayer, M Levy, et al.
Clinical Pharmacology and Therapeutics|July 1, 1983
Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various agesD E Drayer, B Lorenzo, S Werns, et al.
Clinical Pharmacology and Therapeutics|December 1, 1980
Aging and renal clearance of procainamide and acetylprocainamideM M Reidenberg, M Camacho, J Kluger, et al.
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1974
N-acetylprocainamide: an active metabolite of procainamideD E Drayer, M M Reidenberg, R W Sevy
Clinical Pharmacology and Therapeutics|July 1, 1976
Pentobarbital elimination in patients with poor renal functionM M Reidenberg, D T Lowenthal, W Briggs, et al.
Journal of Clinical Epidemiology|October 1, 1994
Breast silicone implants and risk of systemic lupus erythematosusB L Strom, M M Reidenberg, B Freundlich, et al.
Clinical Pharmacology and Therapeutics|January 1, 1982
Age and renal clearance of cimetidineD E Drayer, J Romankiewicz, B Lorenzo, et al.
Annals of Internal Medicine|July 1, 1981
Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndromeJ Kluger, D E Drayer, M M Reidenberg, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1993
Urinary clusterin in chronic nephrotoxicity in the ratS Eti, C Y Cheng, A Marshall, et al.
Clinical Pharmacology and Therapeutics|January 1, 1980
Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with ageD E Drayer, M Hughes, B Lorenzo, et al.
Clinical Pharmacology and Therapeutics|June 1, 1975
Polymorphic acetylation procainamide in manM M Reidenberg, D E Drayer, M Levy, et al.
Clinical Pharmacology and Therapeutics|July 1, 1983
Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various agesD E Drayer, B Lorenzo, S Werns, et al.
Clinical Pharmacology and Therapeutics|December 1, 1980
Aging and renal clearance of procainamide and acetylprocainamideM M Reidenberg, M Camacho, J Kluger, et al.
Pageof 20